Grandiphenol

Grandiphenols: An Encyclopedic Reference

1. Identity and Chemical Classification

Grandiphenols are a family of naturally occurring resveratrol oligomers (oligostilbenoids) isolated from the stem and bark of the tropical hardwood tree Dipterocarpus grandiflorus Blanco (family Dipterocarpaceae). The name is derived directly from the species epithet grandiflorus, and the suffix -phenol reflects the polyphenolic character shared by all resveratrol oligomers from the Dipterocarpaceae family.

Two resveratrol trimers, grandiphenols C and D, were isolated from the stem of Dipterocarpus grandiflorus (Dipterocarpaceae). Earlier work by Ito, Tanaka, Iinuma, and colleagues also documented two resveratrol tetramers from the same species, designated grandiphenols A and B. Two resveratrol tetramers with a tetrahydrofuran ring from Dipterocarpus grandiflorus were reported by Ito et al. in 2004, published in Helvetica Chimica Acta, 87: 479–495. Grandiphenol B has additionally been identified in other Dipterocarpaceae species: two known resveratrol tetramers, grandiphenol B and hopeaphenol A, have been isolated from an acetone extract of the tree bark of Shorea platyclados (Dipterocarpaceae).

Grandiphenols thus span two oligomeric classes within the resveratrol family:

• Grandiphenols A and B — resveratrol tetramers (four resveratrol monomer units), reported as two novel compounds containing a tetrahydrofuran ring, isolated from D. grandiflorus in 2004.
• Grandiphenols C and D — resveratrol trimers (three resveratrol monomer units), reported as two novel compounds isolated from the stem of D. grandiflorus in 2009.

Grandiphenol C has a molecular formula of C₄₂H₃₀O₁₀, while grandiphenol D is C₄₂H₂₈O₁₀. The molecular formula of grandiphenol D differs from grandiphenol C by two hydrogen atoms, indicating an additional degree of unsaturation in its ring system.

Within the broader classification of natural stilbenoids, grandiphenols belong to the subclass of oligostilbenoids, which are secondary metabolites assembled from resveratrol (3,4′,5-trihydroxystilbene, chemical formula C₁₄H₁₂O₃) building blocks. Oligostilbenoids are a group of natural products derived from the oxidative coupling of C₆–C₂–C₆ units found in some plant families. A structurally diverse chemical pool is produced after the successive regioselective and stereoselective oligomerization of resveratrol.

The relationship of grandiphenol C to other known trimers has been described through biogenetic analysis. A similar set of oxidations has been observed for the cyclic 8–10′ trimers, wherein dearomatization of (+)-α-viniferin yields grandiphenol C, which can interconvert to caraphenol A by a dehydration reaction. An oxidation/rearrangement of benzofuran caraphenol A affords grandiphenol D. This places grandiphenols C and D within a biosynthetically unified series of oxidized Dipterocarpaceous resveratrol oligomers. Taken together, these natural products provide a compelling unified mechanism for the biogenesis of the oxidized Dipterocarpaceous resveratrol oligomers.

As a broader context note, in nature, different resveratrol derivatives exist, such as trans- and cis-resveratrol glucosides, dimers (pallidol), trimers (grandiphenol C), α-viniferin, and polymers.

2. Natural Source and Botanical Description

2.1 Source Plant: Dipterocarpus grandiflorus

Dipterocarpus grandiflorus is a species of flowering plant in the Dipterocarpaceae family. It is an endangered medium hardwood tree of Southeast Asia and a large tree which can grow up to 50 metres tall. D. grandiflorus ranges from Bangladesh and the Andaman Islands through Myanmar, Thailand, Laos, Vietnam, Peninsular Malaysia, Sumatra, Borneo, and the Philippines. It grows in lowland evergreen forests, most commonly in primary forests on drier sites and forested ridges, from sea level up to 700 metres elevation.

Dipterocarpus grandiflorus is an emergent tree that can grow up to 45 m tall and 1.5 m in diameter. Trees in the Dipterocarpaceae family are known as "dammar group trees," and like all trees in the dammar group, its stem produces resin. It has leaves which are thick, glabrous (hairless) and leather-like in texture. The species also produces winged fruits that are among the largest in the genus. The calyx tube is about 7 × 3.5 cm, with two major wings of about 22 × 3 cm and another three shorter calyx lobes. The dark purple young leaves and twigs with purple-pink stipules are among physical characteristics that can be used for identification of this species.

Dipterocarpus is the third largest and most diverse genus among Dipterocarpaceae. They are well-known for timber, but less acknowledged for their medicinal importance. The genus has about 70 species, occurring in South Asia and Southeast Asia, from Sri Lanka and India to the Philippines.

2.2 Phytochemical Profile of the Genus

Dipterocarpus has been reported to contain resin, coumarin, and dammar. The resveratrol class of compounds is one of the major chemical constituents in this genus. Generally, the bark of Dipterocarpus is presumed to be the most active.

The phytochemical constituents of the plant genus Dipterocarpus produce a high yield of resveratrol oligomers (oligostilbenoids), sesquiterpenes, and triterpenes. The Dipterocarpaceae family is the most prolific known source of resveratrol oligomers in the plant kingdom. Dipterocarpaceae species synthesize a large variety of resveratrol oligomers, from dimers to oligomers with the highest levels of oligomerization of stilbenes in the plant kingdom, including resveratrol heptamers and the resveratrol octamer (vateriaphenol isolated from Vateria indica).

Structural variations in Vatica, Vateria, Upuna, Cotylelobium, Dipterocarpus, Shorea, and Hopea genera have been examined and about 120 new resveratrol oligomers have been isolated to date. Amongst these families, Dipterocarpaceae, with 50 resveratrol oligomers (REVs), accounts for the majority, and seven genera of Dipterocarpaceae are involved, including Vatica, Vateria, Shorea, Hopea, Neobalanocarpus, and Dipterocarpus.

2.3 Plant Tissue Sources and Preparations

Grandiphenols have been isolated from stem wood and bark of Dipterocarpus grandiflorus. The isolation procedure used in published studies employs extraction with organic solvents (typically acetone), followed by column chromatography and preparative thin-layer chromatography. Column chromatography and preparative thin-layer chromatography were employed to isolate the compounds from D. grandiflorus. Subsequent structural analysis relied on HR-FAB-MS and comprehensive NMR spectral data.

No commercial dietary supplement formulation of isolated grandiphenols has been described in peer-reviewed literature as of the date of this article. The grandiphenols are research-grade phytochemicals studied in academic laboratory settings, not constituents of commercially standardized supplements.

3. Structural Chemistry and Biosynthesis

3.1 Structure Elucidation

The structures of grandiphenols C and D were elucidated by spectral analysis including 1D- and 2D-NMR experiments and by computer-aided molecular modeling. The NMR characteristics caused by the steric hindrance and the biogenetic relationship of the isolates are also discussed in the primary publication.

The structures of grandiphenols C and D were elucidated using ¹H and ¹³C NMR spectroscopy along with 2D NMR techniques. Specifically, the NOESY and COSY methods provided detailed insights into their configurations and relative orientations.

Grandiphenol D features six aromatic rings, including characteristic signals indicating the presence of six phenolic OH groups. Its structure was confirmed through NMR, revealing significant steric hindrance affecting the rotational dynamics of the rings. Steric hindrance significantly influences the spectral characteristics and configurations of these novel compounds.

3.2 Biosynthetic Origin

The biosynthesis of grandiphenols, like all Dipterocarpaceous resveratrol oligomers, proceeds through oxidative coupling of resveratrol monomers. Resveratrol oligomers are metabolites found in a small set of phylogenetically distant plant families, the building block of which (C₆–C₂–C₆) is successively oligomerized after generating phenoxy radicals and highly active quinomethides (QM), followed by spontaneous regioselective radical–radical coupling, regiodivergent Friedel–Crafts reactions, nucleophilic trappings, and tautomerizations.

Beginning with the recently validated formation of resveratrol oligomers in Dipterocarpaceous plants, each downstream conversion is described from the perspective of the resveratrol coupling mode. Particular emphasis is placed upon the regioselectivity of monomer- and dimer-derived radical–radical coupling processes, which are responsible for producing dimers, trimers, and tetramers with various cyclic frame skeletons, as well as related processes that result in highly condensed scaffolds, such as hexamers and octamers.

Grandiphenol C belongs to the 8–10′ trimer skeletal type, placing it biogenetically downstream of α-viniferin. The further oxidized grandiphenol D arises from grandiphenol C via an oxidation/rearrangement pathway involving a benzofuran intermediate (caraphenol A), as described above. The study contributes to understanding biosynthetic pathways of resveratrol oligomers in Dipterocarpaceae.

As secondary metabolites, grandiphenols and related oligostilbenoids function as phytoalexins — defensive compounds produced by the plant in response to biotic stress. Both plants and fungi have been reported to be capable of polymerizing the natural bioactive trihydroxystilbene resveratrol into a host of complex oligomers. In recent years, these resveratrol oligomers have received the attention of natural products researchers worldwide as scientists have come to appreciate their pharmacological potential. Resveratrol oligomers, like many secondary metabolites, are chiefly expressed as biological defense compounds and occur as dimers, trimers, tetramers, and higher-order oligomers in plants.

4. Traditional and Historical Uses

4.1 Ethnobotanical Context of Dipterocarpus grandiflorus

It must be noted at the outset that the ethnobotanical literature documents traditional uses for the whole plant (principally its resin) and for the genus Dipterocarpus broadly, rather than for isolated grandiphenol compounds specifically. No traditional medicinal system has used or characterized the grandiphenol compounds in isolation; their discovery is purely modern and analytical.

Dammar has been one of the major forest resources harvested by the aborigines in Peninsular Malaysia for trading purposes since before the establishment of Melaka as an international port. The resin obtained from Dipterocarpus spp. was also used as varnish, torches, and caulk in Southeast Asia. In modern times, dammar is still used by the aborigines, Malays, and Chinese in Malaysia for spiritual and medicinal purposes, incense, and local trade.

In the Philippines, ethnobotanical surveys have recorded folk medicinal applications of D. grandiflorus. Among documented plants, Dipterocarpus grandiflorus has been used by indigenous communities for kidney and bladder problems.

Plants of the genus Dipterocarpus have been reported to have many bioactivities including antibacterial, antioxidant, cytotoxic, anti-inflammatory, and anti-filarial activities. Extracts of the bark and leaves of D. turbinatus used in Ayurvedic and Unani medicines showed potent cytotoxic activity against breast cancer cell lines.

The genus is of considerable importance as timber trees and for producing resinous oil. The species are well known for timber, but less acknowledged for use in traditional herbal medicine. This indicates that while individual Dipterocarpus species have been used medicinally in regional traditions, the genus has not been a primary subject of codified pharmacopoeia entries in major traditional medicine systems.

4.2 Traditional Preparations

The primary traditional preparation involving D. grandiflorus and related species is the harvested oleoresin (dammar). This resin, obtained by tapping the stem, was used both commercially and medicinally throughout the historical range of the species in South and Southeast Asia. The wood of D. grandiflorus is used to produce good quality charcoal, paper pulp, and timber sold under the Keruing designation. Its gum is used locally as a waterproofing varnish. There is no documented traditional preparation that specifically sought to concentrate resveratrol oligomers such as the grandiphenols.

5. Key Constituents and Mechanisms of Action

5.1 The Grandiphenol Compounds

The grandiphenols — A, B (tetramers) and C, D (trimers) — are characterized by their polyphenolic, multi-ring scaffold structures, each built from resveratrol (3,5,4′-trihydroxystilbene) monomeric units. Resveratrol oligomers are derivatives of resveratrol characterized by the polymerization of two to eight, or even more, resveratrol units, and are the largest group of oligomeric stilbenes.

Resveratrol oligomers differ from most other polyphenols (e.g., flavonoids, pyrones, quinones, and their downstream products) by having comparatively less structural diversity due to small variations and the limited patterns of functional groups; by expanding the chemical pool by oligomerization, the production of various frame skeletons is ensured.

Resveratrol oligomers have multiple beneficial properties, of which some are superior in activity, stability, and selectivity compared with resveratrol monomer.

5.2 General Mechanisms of Action for Resveratrol Oligomers (Class-Level)

Because no mechanistic studies have been published specifically on isolated grandiphenol A, B, C, or D as individual pharmacological agents, the mechanisms discussed here are those established for the broader class of Dipterocarpaceous resveratrol oligomers, to which the grandiphenols biogenetically and structurally belong. These mechanisms are drawn from studies on closely related compounds such as vaticanol C, hopeaphenol, α-viniferin, and ε-viniferin.

• Radical scavenging / antioxidant activity: The ROS scavenging capacity of resveratrol oligomers was 20 times higher than that of the monomers, while the ability of the oligomers to chelate metal ions increased up to about 1,000 times.
• Induction of apoptosis / antiproliferative activity: Vaticanol C-induced apoptosis was associated with the decrease of mitochondrial membrane potential, release of cytochrome c from mitochondria, and activation of caspases-3 and -9, and could be prevented by overexpression of Bcl-2. Molecular studies demonstrated that the mechanism of vaticanol C-induced apoptosis was related to the decrease of pErk, pAkt, and pBad.
• Cell cycle arrest: Hopeaphenol, vaticanol B, hemsleyanol D, and (+)-α-viniferin showed a strong antimelanoma effect against SK-MEL-28 melanoma cells. Other than vaticanol B, the other oligomers can selectively arrest the cell cycle at the G1 phase, resulting in apoptosis of cancer cells.
• Hepatoprotective effects: (−)-Hopeaphenol, (+)-isohopeaphenol, and (+)-α-viniferin, at a dose of 100 or 200 mg/kg p.o., exhibited hepatoprotective effects in liver injuries in mice induced with d-galactosamine/lipopolysaccharide (LPS), by reducing LPS-induced macrophage activation and the sensitivity of hepatocytes to TNF-α.
• Antiviral activity: The resveratrol tetramer vitisin B exhibited a strong inhibition of HCV replication with an EC₅₀ value of 6 nM and showed remarkably low cytotoxicity (EC₅₀ >10 μmol/L).
• Liver cell protection from oxidative damage: The resveratrol dimer ε-viniferin displayed significant activity to protect Chang liver cells from hydrogen peroxide (H₂O₂) damage. When treated with ε-viniferin at 50 μmol/L and 100 μmol/L, the percentage of liver cell viability changed from 78.3% to 106.9% and 111.0%, respectively. The strong antioxidant activity plays an important role in the capacity to protect liver cells.

6. Scientific Evidence by Area of Use

Critical note on evidence status: As of the available peer-reviewed literature, no published human clinical trials, randomized controlled trials, or systematic reviews concern grandiphenols A, B, C, or D specifically. All pharmacological evidence for the grandiphenols themselves is either (a) inferential, by virtue of class membership among Dipterocarpaceous resveratrol oligomers, or (b) based on in vitro (cell-based) and animal model studies of closely related congeners. The grandiphenols are research-stage natural product chemistry entities, not clinically tested interventions.

6.1 Antioxidant Activity

Evidence level: Preliminary; in vitro and structural inference only.

The polyphenolic hydroxyl groups in the grandiphenol scaffold provide the structural basis for free radical scavenging. Resveratrol oligomers as a class have been demonstrated to possess substantially stronger antioxidant activity than resveratrol monomer in standard biochemical assays. Isolated resveratrol oligomers from Dipterocarpaceae were evaluated for their antioxidant activity using the DPPH radical scavenging activity (RSA) and the β-carotene–linoleic acid (BCLA) assays; all compounds tested exhibited good to moderate antioxidant activity in the DPPH assay (IC₅₀s 0.84 to 10.06 mM) and displayed strong inhibition of β-carotene oxidation (IC₅₀s 0.10 to 0.22 mM).

No specific DPPH or ORAC data for grandiphenols A, B, C, or D individually have been published and verified in the sources consulted.

6.2 Anticancer / Cytotoxic Activity

Evidence level: Preliminary; in vitro cell-line studies only; no human data.

Resveratrol oligomers were found to exhibit widely distributed biological activities, such as antibacterial, antifungal, anticancer, anti-HIV, and antioxidant activities. Their intricate structures and diverse biological activities are of significant interest for drug research and development and may provide promising prospects as cancer preventive and therapeutic agents.

Oligomers of catechin, epicatechin, and resveratrol showed antitumor effects in the T24 cell line similar to that observed with cisplatin. Oligomers of catechin, epicatechin, and resveratrol have great potential to be used as therapeutic agents for the treatment of oxidative stress-related diseases and bladder cancer. These findings concern enzymatically produced resveratrol oligomers generally, not grandiphenols specifically.

The antitumor activity of natural resveratrol oligomers is well documented. A variety of resveratrol oligomers exhibited cytotoxicity against various tumor cell lines. For tetramers in the Dipterocarpaceae class most closely related to grandiphenols A and B, resveratrol tetramers are formed from four monomers or two different dimers or a monomer and a trimer, and their complex structures lead to different biological activities. Vaticanol C, isolated from the stem bark of Vatica rassak in Dipterocarpaceae, was reported to exert various pharmacological properties, including antiproliferative, antioxidant, and anti-inflammatory activities.

No direct cytotoxicity IC₅₀ data for grandiphenol A, B, C, or D in human cancer cell lines have been published and verified in the peer-reviewed sources consulted.

6.3 Anti-inflammatory Activity

Evidence level: Preliminary; in vitro and animal data for class members; no human data.

Dipterocarpus species showed anti-AIDS, cytotoxic, anti-inflammatory, antibacterial, antifungal, and antioxidant activities in the broader phytochemical and pharmacological literature. Anti-inflammatory activity reported for Dipterocarpaceous resveratrol oligomers relates primarily to the tetramer hopeaphenol and the tetramer vaticanol C through modulation of TNF-α signaling and macrophage activation pathways, as noted above.

6.4 Antimicrobial Activity

Evidence level: Preliminary; in vitro data for class members.

Resveratrol oligomers from Dipterocarpaceae have demonstrated antimicrobial properties in in vitro assays. Resveratrol is often produced as a defense against microbial infections by Botrytis cinerea, radical damage, UV irradiation, and other stressors. The oligomeric forms including grandiphenol-class compounds share this phytoalexin character. No published minimum inhibitory concentration (MIC) data for grandiphenols A–D individually have been verified in the peer-reviewed sources consulted.

6.5 Hepatoprotective Activity

Evidence level: Preliminary; animal model data for class members only.

As described in the mechanisms section, animal model evidence (d-galactosamine/LPS mouse model) exists for hepatoprotective activity of closely related Dipterocarpaceous tetramers (hopeaphenol, isohopeaphenol, α-viniferin). Whether grandiphenols specifically reproduce these effects has not been tested in published studies.

7. Body Systems and Health Areas of Association

The body systems and health areas with which grandiphenols and their class are associated, based on in vitro and preliminary in vivo research in the peer-reviewed literature, include:

• Cellular oxidative stress / antioxidant defense — via radical scavenging, metal chelation, and protection of cell viability under oxidative challenge.
• Oncology / cell proliferation — in vitro evidence of cytotoxicity and pro-apoptotic activity in cancer cell lines for related Dipterocarpaceous oligomers.
• Hepatic (liver) health — hepatoprotective effects of class members demonstrated in animal models.
• Immune modulation / inflammation — modulation of macrophage activation and TNF-α pathways by Dipterocarpaceous tetramers.
• Antiviral — inhibition of HCV and other viral replication by structurally related tetramers (vitisin B, hopeaphenol).

Resveratrol oligomers (REVs) are biosynthesized by regioselective oxidative coupling of two to eight units of resveratrol monomer. Due to their unique structures and pleiotropic biological activities, natural product chemists are increasingly focusing on REVs in the last few decades.

8. Dosage Forms and Reported Dosages

Because no human clinical trials of grandiphenols have been published, there are no clinically validated dosages for any grandiphenol compound. The following dosages are drawn solely from preclinical (animal model or in vitro) studies of the broader class of Dipterocarpaceous resveratrol oligomers, and are presented only as reported in the cited studies — not as recommendations.

• In vitro cell assays (class members): Concentrations typically employed range from approximately 10 μmol/L to 200 μmol/L in cell culture experiments, as reported for vaticanol C, ε-viniferin, and miyabenol C in published cell-line studies.
• Animal models (class members): (−)-Hopeaphenol, (+)-isohopeaphenol, and (+)-α-viniferin were tested at a dose of 100 or 200 mg/kg, administered orally (p.o.), in a mouse hepatoprotection model.

No information on standardized extract concentrations, capsule dosages, or commercial formulation specifications for grandiphenol-containing products has been identified in authoritative sources.

9. Conservation Status and Availability

Dipterocarpus grandiflorus is an endangered species. The species' habitat is currently in decline in quality and extent across its native range. The endangered status of the source plant raises significant questions regarding the long-term sustainability of grandiphenol isolation from wild-harvested material. Dammar from dipterocarps and other resin-producing plants are susceptible to unsustainable exploitation and illegal harvesting in Malaysia.

The grandiphenol compounds are currently accessible only as research-grade isolates produced by academic extraction from plant material. There is no known large-scale commercial production or synthesis of grandiphenols as dietary supplements.

10. Safety Considerations

No human clinical safety data exist for grandiphenols A, B, C, or D. No formal toxicological studies (acute toxicity, genotoxicity, reproductive toxicity, or chronic toxicity) have been published specifically for these compounds in the peer-reviewed literature consulted.

For reference, related Dipterocarpaceous resveratrol oligomers demonstrated a favorable in vitro safety profile in some cell-line studies: isolated resveratrol oligomers from Dipterocarpaceae were evaluated on the Vero cell line and were found to be non-cytotoxic with LC₅₀ values between 161 to 830 µM.

Resveratrol oligomers have multiple beneficial properties, of which some are superior in activity, stability, and selectivity compared with resveratrol. However, the stability, bioavailability, and metabolism of grandiphenols in human subjects have not been characterized. No drug interaction data specific to grandiphenols have been published. Given the structural similarity to resveratrol — which has documented interactions with cytochrome P450 enzymes and may potentiate anticoagulant effects — these possibilities cannot be excluded, but have not been formally studied for the grandiphenol subclass.

No monograph from the WHO, ESCOP, German Commission E, European Pharmacopoeia, U.S. Pharmacopeia, EMA, EFSA, or NIH Office of Dietary Supplements has been identified for grandiphenols or for Dipterocarpus grandiflorus extracts standardized to grandiphenol content.

11. Summary of Evidence Strength

The grandiphenols are rigorously characterized natural polyphenolic compounds at the level of structural chemistry and phytochemistry, with a well-understood biogenetic origin within the Dipterocarpaceae stilbenoid pathway. The structure, chemistry, and biological activity of the resveratrol oligomers have been reviewed; this includes a thorough examination of the resveratrol oligomers including their roles as phytoalexins, detoxification products of the fungal metabolism of resveratrol, and potential medicinal agents for humans.

However, pharmacological evidence specific to grandiphenol A, B, C, or D as individual agents remains extremely limited. Published bioactivity data are largely inferential from closely related congeners. Although numerous studies have shown various biochemical and pharmacological properties of resveratrol oligomers, there is no systematic review specifically covering grandiphenols. No human clinical data, no pharmacokinetic studies in humans, no established therapeutic dosages, and no regulatory approvals exist for grandiphenols as drugs or dietary supplement ingredients.

References

• Ito T, Abe N, Oyama M, et al. (2009). Two Novel Resveratrol Trimers from Dipterocarpus grandiflorus. Helvetica Chimica Acta, 92(6): 1203–1216. DOI: 10.1002/hlca.200800429
• Ito T, et al. (2009). Two Novel Resveratrol Trimers from Dipterocarpus grandiflorus — Academia.edu (summary and reference)
• Gaur R, et al. (2019). Biotechnological Advances in Resveratrol Production and its Chemical Diversity. PMC/NCBI.
• Kim BG, et al. (2014). Enzymatic Biosynthesis of Novel Resveratrol Glucoside and Glycoside Derivatives. PMC/NCBI.
• Ito T. (2020). Resveratrol Oligomer Structure in Dipterocarpaceaeous Plants. Journal of Natural Medicines. PMC/NCBI.
• Ito T. (2020). Resveratrol oligomer structure in Dipterocarpaceaeous plants. Journal of Natural Medicines. Springer.
• Sotheeswaran S, et al. Resveratrol oligomers: Structure, chemistry, and biological activity. ScienceDirect.
• Xue YQ, et al. (2014). Resveratrol Oligomers for the Prevention and Treatment of Cancers. PMC/NCBI.
• Chen X, et al. (2017). Update on Phytochemistry and Pharmacology of Naturally Occurring Resveratrol Oligomers. Molecules, 22(12): 2050. MDPI.
• Chen X, et al. (2018). Update on Phytochemistry and Pharmacology of Naturally Occurring Resveratrol Oligomers. PMC/NCBI.
• Keylor MH, et al. (2015). Chemistry and Biology of Resveratrol-Derived Natural Products. Chemical Reviews. ACS Publications.
• Ito T, Iinuma M. (2011). Structures of oligostilbenoids in dipterocarpaceaeous plants and their biological activities. PubMed/NCBI.
• Aisyah S, et al. (2014). Two New Ketonic Resveratrol Tetramers from Shorea platyclados. The Natural Products Journal. Bentham Science.
• Foo JB, et al. (2018). Acuminatol and Other Antioxidative Resveratrol Oligomers from the Stem Bark of Shorea acuminata. PMC/NCBI.
• Nivelle L, et al. (2019). Antioxidant Capacity and Cytotoxic Effects of Catechins and Resveratrol Oligomers Produced by Enzymatic Oxidation against T24 Human Urinary Bladder Cancer Cells. PMC/NCBI.
• Wikipedia: Dipterocarpus grandiflorus.
• MyBIS: Dipterocarpus grandiflorus Blanco. Malaysian Biodiversity Information System.
• Phytochemical, Ethnomedicinal and Pharmacological Review of Genus Dipterocarpus. Academia.edu.
• Nawi L, et al. (2024). Chemotaxonomic Relationship of Oligomer Resveratrol in Three Malaysian Dipterocarpus Species. Indonesian Journal of Chemistry. UGM.
• Ethnobotanical Exploration and Biodiversity Conservation of Mt. Nacolod, Southern Leyte, Philippines. InnSPub.